Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

henry schein, inc. - iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611) - infed is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron. infed is contraindicated in patients who have demonstrated a previous hypersensitivity to iron dextran [see warnings and precautions (5.1)]. 8.1 pregnancy risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1)], which may have serious consequences, such as fetal bradycardia (see clinical considerations). advise pregnant persons of the potential risk to the fetus. available data from postmarketing reports with iron dextran use in pregnancy are insufficient to assess the risk of major birth defects or miscarriage. there are risks to the pregnant person and fetus associated with untreated iron deficiency anemia in pregnancy (see clinical considerations). iron dextran has been shown to be teratogenic and embryocidal in mice, rats,

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - ferric derisomaltose, quantity: 4170 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - ferric derisomaltose, quantity: 2085 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - ferric derisomaltose, quantity: 834 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - ferric derisomaltose, quantity: 417 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions: - when oral iron preparations are ineffective or cannot be used; - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - glycerophosphate; iron; ammonium ferric citrate; ferrous sulfate; potassium glycerophosphate; magnesium glycerophosphate; manganese glycerophosphate; sodium glycerophosphate; choline; choline chloride; sorbitol - oral powder, pre-mix - glycerophosphate ungrouped active 21.2 g/l; iron mineral-iron active 11.92 g/l; ammonium ferric citrate mineral-iron active 41.4 g/l; ferrous sulfate mineral-iron active 9.36 g/l; potassium glycerophosphate mineral-potassium active 6.8 g/l; magnesium glycerophosphate mineral-magnesium active 5.43 g/l; manganese glycerophosphate mineral-manganese active 4.6 g/l; sodium glycerophosphate mineral-sodium active 4.37 g/l; choline vitamin-b complex active 0.056 l/l; choline chloride vitamin-b complex active 0.075 l/l; sorbitol carbohydrate other 131.0 g/l - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - metabolic treatment

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

gensavis pharmaceuticals, llc - iron (unii: e1uol152h7) (iron - unii:e1uol152h7), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41) - iron 125 mg in 5 ml - shake well before use. as a dietary supplement for adults and children over 12 years of age: 1 teaspoon (5ml) daily unless otherwise directed by physician (teaspoon enclosed). children under 12 years of age do not take. warning: if you are pregnant or lactating, consult your physician before using this product. distributed by: gensavis pharmaceuticals, llc corpus christi, tx 78415 call 972-836-7783 www.novaferrum.com

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

gensavis pharmaceuticals, llc - iron (unii: e1uol152h7) (iron - unii:e1uol152h7) - iron 15 mg in 1 ml - shake well before use. as a dietary supplement for infants and children under 4 years of age: 1 ml dropper daily unless otherwise directed by physician.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

gensavis pharmaceuticals, llc - iron (unii: e1uol152h7) (iron - unii:e1uol152h7) - iron 50 mg - as a dietary supplement take one capsule daily or as directed by a physician. for adults and children 12 years and older. do not exceed recommended dosage unless otherwise directed by a physician.

Kenya - Inggeris - Pharmacy and Poisons Board

wockhardt limited wockhardt towers, bandra - kurla complex, bandra - ferrous fumarate bp equivalent to elemental iron… - capsule - ferrous fumarate (equivalent to elemental iron 49… - various combinations